Clinical trial
Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation
NCT01190059 is registered in ClinicalTrials.gov with XVIVO Perfusion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation
- Lead sponsor
- XVIVO Perfusion
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2008
- Completion date
- February 28, 2010
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung transplantation